Suche

Programmdetails

Postervorträge

Inflammation bei kardiovaskulären Erkrankungen

Donnerstag, 24. April | 14:30 - 15:30 Uhr | Posterbereich 20

Vorsitz/Chair: Ingo Hilgendorf (Freiburg im Breisgau), Stefanie Jellinghaus (Dresden)

Agenda

(P621)
Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2
E. Schieffer (Marburg)
(P622)
Plasma GLP-1 levels predict mortality in patients with COVID-19: The COVID-19 Aachen Study (COVAS)
N. Tabaza (Aachen)
(P623)
Multifactorial etiology of arrhythmogenic cardiomyopathy: Interactions between gene mutation, viral infection and age in Pkp2+/- mice
A. Cirnu (Würzburg)
(P624)
Greater Improvement in Endothelial Function and Reduced Inflammation with SELUTION SLR Sirolimus-Eluting Balloon Compared to IN.PACT Paclitaxel-Coated Balloon
O. Petrikhovich (Essen)
(P625)
CRIP1 as a Novel Regulator of NLRP3 Inflammasome Activation in Hypertension
T. Tong (Lübeck)
(P626)
Cardiac arrhythmogenesis in Experimental Autoimmune Myocarditis (EAM) model
A. S. Chivukula (München)
(P627)
Does MCMV trigger Pkp2-associated arrhythmogenic cardiomyopathy? Immune phenotyping and heart function at a stage of early latency
K. Svenja (Würzburg)
Diese Seite teilen